Advances in breast conservation therapy

Journal of Clinical Oncology

Volumn 23, Issue 8, 2005, Pages 1685-1697

  Newman, Lisa A ^a   Kuerer, Henry M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN;

BREAST CANCER; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CONSERVATIVE TREATMENT; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; HEALTH CARE UTILIZATION; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL MASTECTOMY; PRIORITY JOURNAL; REVIEW; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FACTUAL DATABASE; FEMALE; GENETICS; METHODOLOGY; MUTATION; PAGET NIPPLE DISEASE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SEGMENTAL MASTECTOMY; STATISTICS; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; DATABASES, FACTUAL; FEMALE; GENES, BRCA1; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY, SEGMENTAL; MUTATION; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS;

EID: 15544383380     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.09.046     Document Type: Review

References (169)

1. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 265:391-395, 1991
2. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
3. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002
4. Poggi MM, Danforth DN, Sciuto LC, et al: Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: The National Cancer Institute Randomized Trial. Cancer 98:697-702, 2003
5. Van Dongen J, Bartelink H, Fentiman I: Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 28A:801-805, 1992
6. van Dongen JA, Voogd AC, Fentiman IS, et al: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92:1143-1150, 2000
7. Sarrazin D, Le MG, Arriagada R, et al: Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 14:177-184, 1989
8. Blichert-Toft M, Rose CA, Anderson J: Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis, Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 11:19-25, 1992
9. Voogd AC, Nielsen M, Peterse JL, et al: Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials. J Clin Oncol 19:1688-1697, 2001
10. Morris AD, Morris RD, Wilson JF, et al: Breast-conserving therapy vs mastectomy in early-stage breast cancer: A meta-analysis of 10-year survival. Cancer J Sci Am 3:6-12, 1997
11. Morrow M, White J, Moughan J, et al: Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 19:2254-2262, 2001
12. Locker G, Sainsbury R, Cuzick J: The ATAC Trialists' Group. Breast surgery in the ATAC trial: Women from the United States are more likely to have mastectomy, San Antonio Breast Cancer Symposium. San Antonio, Texas, 2002
13. Swanson GM, Satariano ER, Satariano WA, et al: Trends in conserving treatment of invasive carcinoma of the breast in females. Surg Gynecol Obstet 171:465-471, 1990
14. Samet JM, Hunt WC, Farrow DC: Determinants of receiving breast-conserving surgery. The Surveillance, Epidemiology, and End Results Program, 1983-1986. Cancer 73:2344-2351, 1994
15. Johantgen ME, Coffey RM, Harris DR, et al: Treating early-stage breast cancer: Hospita characteristics associated with breast-conserving surgery. Am J Public Health 85:1432-1434, 1995
16. Ayanian JZ, Guadagnoli E: Variations in breast cancer treatment by patient and provider characteristics. Breast Cancer Res Treat 40:65-74, 1996
17. Nattinger AB, Gottlieb MS, Veum J, et al: Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med 326:1102-1107, 1992
18. Lucci A, Shoher A, Sherman M, et al: Assessment of the current Medicare reimbursement system for breast cancer operations. Society of Surgical Oncology Annual Cancer Symposium, New York, NY, 2004, p S75 (abstr 84)
19. Holli K, Saaristo R, Isola J, et al: Lumpectomy with or without postoperative radiotherapy for breast cancer with favorable prognostic features: Results of a randomized study. Br J Cancer 84:164-169, 2001
20. Clark R, Whelan T, Levine M, et al: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: An update. J Natl Cancer Inst 88:1659-1664, 1996
21. Forrest A, Stewart H, Everington D, et al: Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 348:708-713, 1996
22. Inoue M, Tanaka H, Masuda R, et al: Local control and cosmetic outcome after sector resection with or without radiation therapy for early breast cancer. Breast Cancer 3:39-46, 1996
23. Veronesi U, Marubini E, Mariani L, et al: Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 12:997-1003, 2001
24. Recht A, Edge SB, Solm LJ, et al: Post-mastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1539-1569, 2001
25. Vinh-Hung V, Verschraegen C: Breast-conserving surgery with or without radiotherapy: Pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96:115-121, 2004
26. Morrow M, Strom EA, Bassett LW, et al: Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 52:277-300, 2002
27. Brekelmans CT, Voogd AC, Botke G, et al: Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Eur J Cancer 35:620-626, 1999
28. Chabner E, Nixon A, Gelman R, et al: Family history and treatment outcome in young women after breast-conserving surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 16:2045-2051, 1998
29. Vlastos G, Mirza NQ, Meric F, et al: Breast-conservation therapy in early-stage breast cancer patients with a positive family history. Ann Surg Oncol 9:912-919, 2002
30. Voogd AC, Peterse JL, Crommelin MA, et al: Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST). Eur J Cancer 35:1828-1837, 1999
31. Salvador: B, Biganzoli E, Veronesi P, et al: Conservative surgery for infiltrating tabular breast carcinoma. Br J Surg 84:106-109, 1997
32. Elkhuizen PH, Voogd AC, van den Broek LC, et al: Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: A case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys 45:73-83, 1999
33. Wazer DE, Schmidt-Ullrich RK, Ruthazer R, et al: Factors determining outcome for breast-conserving irradiation with margin-directed dose escalation to the tumor bed. Int J Radiat Oncol Biol Phys 40:851-858, 1998
34. Holland PA, Shah A, Howell A, et al: Lobular carcinoma of the breast can be managed by breast-conserving therapy. Br J Surg 82:1364-1366, 1995
35. Schnitt SJ, Connolly JL, Recht A, et al: Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy. Cancer 64:448-454, 1989
36. Abner AL, Connolly JL, Recht A, et al: The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer 88:1072-1077, 2000
37. Carolin KA, Tekyi-Mensah S, Pass HA: Lobular carcinoma in situ and invasive cancer: The contralateral breast controversy. Breast J 8:263-268, 2002
38. Moran M, Haffty BG: Lobular carcinoma in situ as a component of breast cancer: The long-term outcome in patients treated with breast-conservation therapy. Int J Radiat Oncol Biol Phys 40:353-358, 1998
39. Hussien M, Lioe T, Finnegan J, et al: Surgical treatment for invasive lobular carcinoma of the breast. Breast 12:23-35, 2003
40. Sasson AR, Fowble B, Hanlon AL, et al: Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer 91:1862-1869, 2001
41. Winchester DP, Cox JD: Standards for diagnosis and management of invasive breast carcinoma: American College of Radiology, American College of Surgeons, College of American Pathologists. Society of Surgical Oncology. CA Cancer J Clin 48:83-107, 1998
42. Veronesi U, Salvadori B, Luini A, et al: Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. Eur J Cancer 31 A:1574-1579, 1995
43. Spivack B, Khanna MM, Tafra L, et al: Margin status and local recurrence after breast-conserving surgery. Arch Surg 129:952-957, 1994
44. Noguchi S, Koyama H, Kasugai T, et al: A case-control study on risk factors for local recurrences or distant metastases in breast cancer patients treated with breast-conserving surgery. Oncology 54:468-474, 1997
45. Slotman BJ, Meyer OW, Njo KH, et al: Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother Oncol 30:206-212, 1994
46. Borger J, Kemperman H, Hart A, et al: Risk factors in breast-conservation therapy. J Clin Oncol 12:653-660, 1994
47. Burke MF, Allison R, Tripcony L: Conservative therapy of breast cancer in Queensland. Int J Radiat Oncol Biol Phys 31:295-303, 1995
48. Heimann R, Powers C, Halpem HJ, et al: Breast preservation in stage I and II carcinoma of the breast. The University of Chicago experience. Cancer 78:1722-1730, 1996
49. Dewar JA, Arriagada R, Benhamou S, et al: Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). IGR Breast Cancer Group. Cancer 76:2260-2265, 1995
50. Mansfield CM, Komarnicky LT, Schwartz GF, et al: Ten-year results in 1070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer 75:2328-2336, 1995
51. Leong C, Boyages J, Jayasinghe UW, et al: Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 100:1823-1832, 2004
52. Newman LA, Washington TA: New trends in breast conservation therapy. Surg Clin North Am 83:841-883, 2003
53. Singletary SE: Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 184:383-393, 2002
54. Veronesi U: How important is the assessment of resection margins in conservative surgery for breast cancer? Cancer 74:1660-1661, 1994
55. Veronesi U, Luini A, Galimberti V, et al: Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials. World J Surg 18:70-75, 1994
56. Veronesi U, Volterrani F, Luini A, et al: Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26:671-673, 1990
57. Ryoo MC, Kagan AR, Wollin M, et al: Prognostic factors for recurrence and cosmesis in 393 patients after radiation therapy for early mammary carcinoma. Radiology 172:555-559, 1989
58. Touboul E, Buffat L, Belkacemi Y, et al: Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43:25-38, 1999
59. DiBiase SJ, Komarnicky LT, Schwartz GF, et al: The number of positive margins influences the outcome of women treated with breast preservation for early stage breast carcinoma. Cancer 82:2212-2220, 1998
60. Freedman G, Fowble B, Hanlon A, et al: Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy. Int J Radiat Oncol Biol Phys 44:1005-1015, 1999
61. Gould EW, Robinson PG: The pathologist's examination of the "lumpectomy"-the pathologists' view of surgical margins. Semin Surg Oncol 8:129-135, 1992
62. Schnitt SJ, Connolly JL, Harris JR, et al: Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy. Cancer 53:1049-1057, 1984
63. Holland R, Connolly JL, Gelman R, et al: The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8:113-118, 1990
64. Gage I, Schnitt SJ, Nixon AJ, et al: Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 78:1921-1928, 1996
65. Leborgne F, Leborgne JH, Ortega B, et al: Breast conservation treatment of early stage breast cancer: Patterns of failure. Int J Radiat Oncol Biol Phys 31:765-775, 1995
66. Boyages J, Recht A, Connolly JL, et al: Early breast cancer: Predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 19:29-41, 1990
67. Schnitt SJ, Abner A, Gelman R, et al: The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 74:1746-1751, 1994
68. Anscher MS, Jones P, Prosnitz LR, et al: Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy. Ann Surg 218:22-28, 1993
69. Smitt MC, Nowels KW, Zdeblick MJ, et al: The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 76:259-267, 1995
70. Mirza NQ, Vlastos G, Meric F, et al: Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 9:256-265, 2002
71. Dalberg K, Mattsson A, Rutqvist LE, et al: Breast conserving surgery for invasive breast cancer: Risk factors for ipsilateral breast tumor recurrences. Breast Cancer Res Treat 43:73-86, 1997
72. Arriagada R, Le MG, Guinebretiere JM, et al: Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 14:1617-1622, 2003
73. Jobsen JJ, van der Palen J, Ong F, et al: The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only. Int J Radiat Oncol Biol Phys 57:724-731, 2003
74. Orel SG, Schnall MD: MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 220:13-30, 2001
75. Morris EA: Review of breast MRI: Indications and limitations. Semin Roentgenol 36:226-237, 2001
76. Chen C, Orel SG, Harris E, et al: Outcome after treatment of patients with mammographically occult, magnetic resonance imaging-detected breast cancer presenting with axillary lymphadenopathy. Clin Breast Cancer 5:72-77, 2004
77. Baker DR: Magnetic resonance imaging of occult breast cancer. Clin Breast Cancer 1:66-67, 2000
78. Olson JA, Jr., Morris EA, Van Zee KJ, et al: Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 7:411-415, 2000
79. Davis PL, Julian TB, Staiger M, et al: Magnetic resonance imaging detection and wire localization of an 'occult' breast cancer. Breast Cancer Res Treat 32:327-330, 1994
80. Tan JE, Orel SG, Schnall MD, et al: Role of magnetic resonance imaging and magnetic resonance imaging-guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol 22:414-418, 1999
81. Fischer U, Kopka L, Grabbe E: Breast carcinoma: Effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213:881-888, 1999
82. Lee JM, Orel SG, Czerniecki BJ, et al: MRI before reexcision surgery in patients with breast cancer. AJR Am J Roentgenol 182:473-480, 2004
83. Rodenko GN, Harms SE, Pruneda JM, et al: MR imaging in the management before surgery of lobular carcinoma of the breast: Correlation with pathology. AJR Am J Roentgenol 167:1415-1419, 1996
84. Schelfout K, Van Goethem M, Kersschot E, et al: Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol 14:1209-1216, 2004
85. Uematsu T, Sano M, Homma K, et al: Value of three-dimensional helical CT image-guided planning for made-to-order lumpectomy in breast cancer patients. Breast J 10:33-37, 2004
86. Henry-Tillman R, Johnson A, Smith L, et al: Intraoperative ultrasound and other techniques to achieve negative margins. Semin Surg Oncol 20:206-213, 2001
87. Rahusen FD, Bremers AJ, Fabry HF, et al: Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: A randomized clinical trial. Ann Surg Oncol 4:994-998, 2002
88. Berg WA, Gilbreath PL: Multicentric and multifocal cancer: Whole-breast US in preoperative evaluation. Radiology 214:59-66, 2000
89. Moon WK, Noh DY, Im JG: Multifocal, multicentric, and contralateral breast cancers: Bilateral whole-breast US in the preoperative evaluation of patients. Radiology 224:569-576, 2002
90. Malur S, Wurdinger S, Moritz A, et al: Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography. Breast Cancer Res 3:55-60, 2001
91. Hata T, Takahashi H, Watanabe K, et al: Magnetic resonance imaging for preoperative evaluation of breast cancer: A comparative study with mammography and ultrasonography. J Am Coll Surg 198:190-197, 2004
92. Morrow M: Magnetic resonance imaging in the preoperative evaluation of breast cancer: Primum non nocere. J Am Coll Surg 198:240-241, 2004
93. Robson M, Levin D, Federici M, et al: Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations. J Natl Cancer Inst 91:2112-2117, 1999
94. Haffty BG, Harrold E, Khan AJ, et al: Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet 359:1471-1477, 2002
95. Pierce LJ, Strawderman M, Narod SA, et al: Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 18:3360-3369, 2000
96. Pierce L, Levin A: T R, et al: Ten-year outcome of breast-conserving surgery (BCS) and radiotherapy (RT) in women with breast cancer (BC) and germline BRCA 1/2 mutations: Results from an international collaboration. San Antonio Breast Cancer Symposium, San Antonio, TX, 2003 (abstr 5)
97. Verhoog LC, Brekelmans CT, Seynaeve C, et al: Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 351:316-321, 1998
98. Eccles D, Simmonds P, Goddard J, et al: Familial breast cancer: An investigation into the outcome of treatment for early stage disease. Fam Cancer 1:65-72, 2001
99. Delaloge S, Kloos I, Ariane D, et al: Young age is the major predictor of local relapse among conservatively treated BRCA1- BRCA2- or non-BRCA-linked hereditary breast cancer. Proc Am Soc Clin Oncol 22:11, 2003 (abstr 41)
100. El-Tamer M, Russo D, Troxel A, et al: Survival and recurrence after breast cancer in BRCA1/2 mutation carriers. Ann Surg Oncol 11:157-164, 2004
101. Seynaeve C, Verhoog LC, van de Bosch LM, et al: Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy. Eur J Cancer 40:1150-1158, 2004
102. Robson ME, Chappuis PO, Satagopan J, et al: A combined analysis of outcome following breast cancer: Differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res 6:R8-R17, 2004
103. Hunt KK, Ames FC, Singletary SE, et al: Locally advanced noninflammatory breast cancer. Surg Clin North Am 76:393-410, 1996
104. Newman LA: Management of patients with locally advanced breast cancer. Curr Oncol Rep 6:53-61, 2004
105. Singletary SE, McNeese MD, Hortobagyi GN: Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma. Cancer 69:2849-2852, 1992
106. Mauriac L, Durand M, Avril A, et al: Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre. Ann Oncol 2:347-354, 1991
107. Mauriac L, MacGrogan G, Avril A, et al: Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS). Ann Oncol 10:47-52, 1999
108. Scholl SM, Asselain B, Palangie T, et al: Neoadjuvant chemotherapy in operable breast cancer. Eur J Cancer 27:1668-1671, 1991
109. Scholl SM, Fourquet A, Asselain B, et al: Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6. Eur J Cancer 30A:645-652, 1994
110. Scholl SM, Pierga JY, Asselain B, et al: Breast tumour response to primary chemotherapy predicts local and distant control as well as survival. Eur J Cancer 31 A:1969-1975, 1995
111. Powles TJ, Hickish TF, Makris A, et al: Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 13:547-552, 1995
112. Makris A, Powles TJ, Ashley SE, et al: A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer. Ann Oncol 9:1179-1184, 1998
113. Makris A, Powles TJ, Dowsett M, et al: Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas. Clin Cancer Res 3:593-600, 1997
114. Fisher B, Brown A, Mamounas E, et al: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483-2493, 1997
115. Fisher B, Bryant J, Wolmark N, et al: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16:2672-2685, 1998
116. Wolmark N, Wang J, Mamounas E, et al: Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr:96-102, 2001
117. van der Hage JA, van de Velde CJ, Julien JP, et al: Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19:4224-4237, 2001
118. Gianni L, Baselga J, Eiermann W, et al: First report of the European Cooperative Trial in Operable Breast Cancer (ECTO): Effects of primary systemic therapy (PST) on local-regional disease. Proc Am Soc Clin Oncol 21:2002 (abstr 132)
119. Jakesz R, Group ABCCS: Comparison of pre- vs. postoperative chemotherapy in breast cancer patients: Four-year results of Austrian Breast and Colorectal Study Group (ABCSG) Trial 7. Proc Am Soc Clin Oncol 20:2001 (abstr 125)
120. Ring A, Webb A, Ashley S, et al: Is surgery necessary after complete clinical remission following neoadjuvant chemotherapy for early breast cancer? J Clin Oncol 21:4540-4545, 2003
121. Newman LA, Buzdar AU, Singletary SE, et al: A prospective trial of preoperative chemotherapy in resectabie breast cancer: Predictors of breast-conservation therapy feasibility. Ann Surg Oncol 9:228-234, 2002
122. Mathieu MC, Rouzier R, Llombart-Cussac A, et al: The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer 40:342-351, 2004
123. Akashi-Tanaka S, Fukutomi T, Sato N, et al: The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery. Ann Surg 239:238-243, 2004
124. Akashi-Tanaka S, Fukutomi T, Sato N, et al: The role of computed tomography in the selection of breast cancer treatment. Breast Cancer 10:198-203, 2003
125. Rosen EL, Blackwell KL, Baker JA, et al: Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. AJR Am J Roentgenol 181:1275-1282, 2003
126. Warren RM, Bobrow LG, Earl HM, et al: Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer 90:1349-1360, 2004
127. Martincich L, Montemurro F, De Rosa G, et al: Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 83:67-76, 2004
128. Londero V, Bazzocchi M, Del Frate C, et al: Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol 14:1371-1379, 2004
129. Burcombe RJ, Makris A, Pittam M, et al: Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography. Eur J Cancer 38:375-379, 2002
130. Nakamura S, Kenjo H, Nishio T, et al: 3D-MR mammography-guided breast conserving surgery after neoadjuvant chemotherapy: Clinical results and future perspectives with reference to FDG-PET. Breast Cancer 8:351-354, 2001
131. Pierce LJ, Haffty BG, Solin LJ, et al: The conservative management of Paget's disease of the breast with radiotherapy. Cancer 80:1065-1072, 1997
132. Kurtz JM, Jacquemier J, Amalric R, et al: Breast-conserving therapy for macroscopically multiple cancers. Ann Surg 212:38-44, 1990
133. Leopold KA, Recht A, Schnitt SJ, et al: Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. Int J Radiat Oncol Biol Phys 16:11-16, 1989
134. Wilson LD, Beinfield M, McKhann CF, et al: Conservative surgery and radiation in the treatment of synchronous ipsilateral breast cancers. Cancer 72:137-142, 1993
135. Hartsell WF, Recine DC, Griem KL, et al: Should multicentric disease be an absolute contraindication to the use of breast-conserving therapy? Int J Radiat Oncol Biol Phys 30:49-53, 1994
136. Cho LC, Senzer N, Peters GN: Conservative surgery and radiation therapy for macroscopically multiple ipsilateral invasive breast cancers. Am J Surg 183:650-654, 2002
137. Kaplan J, Giron G, Tartter PI, et al: Breast conservation in patients with multiple ipsilateral synchronous cancers. J Am Coll Surg 197:726-729, 2003
138. Okumura S, Mitsumori M, Yamauchi C, et al: Feasibility of breast-conserving therapy for macrosoopically multiple ipsilateral breast cancer. Int J Radiat Oncol Biol Phys 59:146-151, 2004
139. Fisher B, Anderson S, Fisher ER, et al: Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338:327-331, 7991
140. Veronesi U, Marubini E, Del Vecchio M, et al: Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events. J Natl Cancer Inst 87:19-27, 1995
141. Fredriksson I, Liljegren G, Arnesson LG, et al: Local recurrence in the breast after conservative surgery-a study of prognosis and prognostic factors in 391 women. Eur J Cancer 38:1860-1870, 2002
142. Voogd AC, van Tienhoven G, Peterse HL, et al: Local recurrence after breast conservation therapy for early stage breast carcinoma: Detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Cancer 85:437-446, 1999
143. Cajucom CC, Tsangaris TN, Nemoto T, et al: Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy. Cancer 71:1774-1779, 1993
144. Haffty BG, Fischer D, Beinfield M, et al: Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys 21:293-298, 1991
145. Gage I, Schnitt SJ, Recht A, et al: Skin recurrences after breast-conserving therapy for early-stage breast cancer. J Clin Oncol 16:480-486, 1998
146. Clarke DH, Le MG, Sarrazin D, et al: Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 11:137-145, 1985
147. Whelan T, Clark R, Roberts R, et al: Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: Results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Radiat Oncol Biol Phys 30:11-16, 1994
148. Doyle T, Schultz DJ, Peters C, et al: Long-term results of local recurrence after breast conservation treatment for invasive breast cancer. Int J Radiat Oncol Biol Phys 51:74-80, 2001
149. Haffty BG, Reiss M, Beinfield M, et al: Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol 14:52-57, 1996
150. Recht A, Schnitt SJ, Connolly JL, et al: Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. Int J Radiat Oncol Biol Phys 16:3-9, 1989
151. Kurtz JM, Jacquemier J, Amalric R, et al: Is breast conservation after local recurrence feasible? Eur J Cancer 27:240-244, 1991
152. Abner AL, Recht A, Eberlein T, et al: Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 11:44-48, 1993
153. Maulard C, Housset M, Brunel P, et al: Use of perioperative or split-course interstitial brachytherapy techniques for salvage irradiation of isolated local recurrences after conservative management of breast cancer. Am J Clin Oncol 18:348-352, 1995
154. Dalberg K, Mattsson A, Sandelin K, et al: Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer. Breast Cancer Res Treat 49:69-78, 1998
155. Salvadori B, Marubini E, Miceli R, et al: Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery. Br J Surg 86:84-87, 1999
156. Deutsch M: Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation. Int J Radiat Oncol Biol Phys 53:687-691, 2002
157. Resch A, Fellner C, Mock U, et al: Locally recurrent breast cancer: pulse dose rate brachy-therapy for repeat irradiation following lumpectomy-a second chance to preserve the breast. Radiology 225:713-718, 2002
158. Kuerer HM, Arthur DW, Haffty BG: Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence. Cancer 100:2269-2280, 2004
159. Cox CE, Reintgen DS, Nicosia SV, et al: Analysis of residual cancer after diagnostic breast biopsy: An argument for fine-needle aspiration cytology. Ann Surg Oncol 2:201-206, 1995
160. Staradub VL, Rademaker AW, Morrow M: Factors influencing outcomes for breast conservation therapy of mammographically detected malignancies. J Am Coll Surg 196:518-524, 2003
161. Liberman L, Goodstine SL, Dershaw DD, et al: One operation after percutaneous diagnosis of nonpalpable breast cancer: Frequency and associated factors. AJR Am J Roentgenol 178:673-679, 2002
162. Tartter PI, Bleiweiss IJ, Levchenko S: Factors associated with clear biopsy margins and clear reexcision margins in breast cancer specimens from candidates for breast conservation. J Am Coll Surg 185:268-273, 1997
163. Luu HH, Otis CN, Reed WP, Jr., et al: The unsatisfactory margin in breast cancer surgery. Am J Surg 178:362-366, 1999
164. Cox CE, Ku NN, Reintgen DS, et al: Touch preparation cytology of breast lumpectomy margins with histologic correlation. Arch Surg 126:490-493, 1991
165. Klimberg VS, Westbrook KC, Korourian S: Use of touch preps for diagnosis and evaluation of surgical margins in breast cancer. Ann Surg Oncol 5:220-226, 1998
166. Cox CE, Pendas S, Ku NN, et al: Local recurrence of breast cancer after cytological evaluation of lumpectomy margins. Am Surg 64:533-538, 1998
167. Klimberg VS, Harms S, Korourian S: Assessing margin status. Surg Oncol 8:77-84, 1999
168. Barthelmes L, Al Awa A, Crawford DJ: Effect of cavity margin shavings to ensure completeness of excision on local recurrence rates following breast conserving surgery. Eur J Surg Oncol 29:644-648, 2003
169. Rubio IT, Mirza N, Sahin AA, et al: Role of specimen radiography in patients treated with skin-sparing mastectomy for ductal carcinoma in situ of the breast. Ann Surg Oncol 7:544-548, 2000